Does racial variation in risk factors explain black-white differences in the incidence of hypertensive end-stage renal disease? - PubMed (original) (raw)
. 1991 Jul;151(7):1359-64.
Affiliations
- PMID: 2064486
Does racial variation in risk factors explain black-white differences in the incidence of hypertensive end-stage renal disease?
J C Whittle et al. Arch Intern Med. 1991 Jul.
Abstract
Prospectively collected data on the incidence of treated hypertensive end-stage renal disease (HT-ESRD) were analyzed to investigate whether the higher rate of HT-ESRD in blacks compared with whites is due to differences in putative ESRD risk factors. The overall age-adjusted relative risks of HT-ESRD for black compared with white residents in the Maryland Regional ESRD Registry (Network 31) Catchment Area were 7.4 (95% confidence interval, 5.9 to 9.4) and 9.9 (95% confidence interval, 7.4 to 13.1) for men and women, respectively. In a population level analysis, race-specific HT-ESRD incidence rates in the black and white populations of 13 regions in Network 31 were related to the prevalence of putative ESRD risk factors in those populations. The latter were estimated from the 1981-1982 Maryland Statewide Household Hypertension Survey. Black populations had a 5.6-fold (95% confidence interval, 3.9 to 8.1) higher unadjusted incidence of HT-ESRD than white populations. The HT-ESRD incidence in a population was also directly related to that population's prevalence of hypertension, severe hypertension, and diabetes mellitus and inversely related to measures of socioeconomic status and mean age at diagnosis of hypertension. When adjusted simultaneously for age, prevalence of hypertension, severe hypertension, diabetes, and level of education, the risk of HT-ESRD was still 4.5 (95% confidence interval, 3.2 to 6.2) times higher for black compared with white populations. Our findings failed to support the hypothesis that race-related differences in the prevalence, severity, or age at onset of hypertension, in the prevalence of diabetes or in socioeconomic status, explain the well-recognized black-white differences in the HT-ESRD incidence.
Comment in
- Time for action.
Tierney WM, Harris LE, Luft FC. Tierney WM, et al. Arch Intern Med. 1991 Jul;151(7):1272-4. Arch Intern Med. 1991. PMID: 2064476 No abstract available.
Similar articles
- The excess incidence of diabetic end-stage renal disease among blacks. A population-based study of potential explanatory factors.
Brancati FL, Whittle JC, Whelton PK, Seidler AJ, Klag MJ. Brancati FL, et al. JAMA. 1992 Dec 2;268(21):3079-84. JAMA. 1992. PMID: 1433738 - Racial differences in the incidence of hypertensive end-stage renal disease (ESRD) are not entirely explained by differences in the prevalence of hypertension.
McClellan W, Tuttle E, Issa A. McClellan W, et al. Am J Kidney Dis. 1988 Oct;12(4):285-90. doi: 10.1016/s0272-6386(88)80221-x. Am J Kidney Dis. 1988. PMID: 3263042 - Relationships of race and ethnicity to progression of kidney dysfunction and clinical outcomes in patients with chronic kidney failure.
Lopes AA. Lopes AA. Adv Ren Replace Ther. 2004 Jan;11(1):14-23. doi: 10.1053/j.arrt.2003.10.006. Adv Ren Replace Ther. 2004. PMID: 14730535 Review. - End-stage renal disease and race: an overview and perspective.
Ferguson R. Ferguson R. J Natl Med Assoc. 1991 Sep;83(9):794-8. J Natl Med Assoc. 1991. PMID: 1942113 Free PMC article. Review.
Cited by
- Proposal for mapping renal failure in Japan and its application for strategy to arrest endstage renal disease.
Usami T, Kimura G. Usami T, et al. Clin Exp Nephrol. 2006 Mar;10(1):8-12. doi: 10.1007/s10157-005-0404-5. Clin Exp Nephrol. 2006. PMID: 16544172 Review. - Association of adiponectin gene polymorphisms with type 2 diabetes in an African American population enriched for nephropathy.
Bostrom MA, Freedman BI, Langefeld CD, Liu L, Hicks PJ, Bowden DW. Bostrom MA, et al. Diabetes. 2009 Feb;58(2):499-504. doi: 10.2337/db08-0598. Epub 2008 Dec 3. Diabetes. 2009. PMID: 19056609 Free PMC article. - Genetic variation in APOL1 and MYH9 genes is associated with chronic kidney disease among Nigerians.
Tayo BO, Kramer H, Salako BL, Gottesman O, McKenzie CA, Ogunniyi A, Bottinger EP, Cooper RS. Tayo BO, et al. Int Urol Nephrol. 2013 Apr;45(2):485-94. doi: 10.1007/s11255-012-0263-4. Epub 2012 Sep 7. Int Urol Nephrol. 2013. PMID: 22956460 Free PMC article. - Poverty and racial disparities in kidney disease: the REGARDS study.
McClellan WM, Newsome BB, McClure LA, Howard G, Volkova N, Audhya P, Warnock DG. McClellan WM, et al. Am J Nephrol. 2010;32(1):38-46. doi: 10.1159/000313883. Epub 2010 May 31. Am J Nephrol. 2010. PMID: 20516678 Free PMC article. - End stage renal disease risk and neighbourhood deprivation: a nationwide cohort study in Sweden.
Akrawi DS, Li X, Sundquist J, Sundquist K, Zöller B. Akrawi DS, et al. Eur J Intern Med. 2014 Nov;25(9):853-9. doi: 10.1016/j.ejim.2014.09.016. Epub 2014 Oct 5. Eur J Intern Med. 2014. PMID: 25294596 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical